These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31473189)

  • 1. Accrual of older adults to cancer clinical trials led by the Canadian cancer trials group - Is trial design a barrier?
    Hernandez-Torres C; Cheung WY; Kong S; O'Callaghan CJ; Hsu T
    J Geriatr Oncol; 2020 Apr; 11(3):455-462. PubMed ID: 31473189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth in eligibility criteria content and failure to accrue among National Cancer Institute (NCI)-affiliated clinical trials.
    Peterson JS; Plana D; Bitterman DS; Johnson SB; Aerts HJWL; Kann BH
    Cancer Med; 2023 Feb; 12(4):4715-4724. PubMed ID: 36398619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary evaluation of factors associated with premature trial closure and feasibility of accrual benchmarks in phase III oncology trials.
    Schroen AT; Petroni GR; Wang H; Gray R; Wang XF; Cronin W; Sargent DJ; Benedetti J; Wickerham DL; Djulbegovic B; Slingluff CL
    Clin Trials; 2010 Aug; 7(4):312-21. PubMed ID: 20595245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving accrual of older persons to cancer treatment trials: a randomized trial comparing an educational intervention with standard information: CALGB 360001.
    Kimmick GG; Peterson BL; Kornblith AB; Mandelblatt J; Johnson JL; Wheeler J; Heinze R; Cohen HJ; Muss HB
    J Clin Oncol; 2005 Apr; 23(10):2201-7. PubMed ID: 15800312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoting Accrual of Older Patients with Cancer to Clinical Trials: An Alliance for Clinical Trials in Oncology Member Survey (A171602).
    Freedman RA; Dockter TJ; Lafky JM; Hurria A; Muss HJ; Cohen HJ; Jatoi A; Kemeny MM; Ruddy KJ
    Oncologist; 2018 Sep; 23(9):1016-1023. PubMed ID: 29674441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eligibility criteria for phase I clinical trials: tight vs loose?
    Malik L; Lu D
    Cancer Chemother Pharmacol; 2019 May; 83(5):999-1002. PubMed ID: 30809701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accrual of Older Patients With Breast Cancer to Alliance Systemic Therapy Trials Over Time: Protocol A151527.
    Freedman RA; Foster JC; Seisler DK; Lafky JM; Muss HB; Cohen HJ; Mandelblatt J; Winer EP; Hudis CA; Partridge AH; Carey LA; Cirrincione C; Moreno-Aspitia A; Kimmick G; Jatoi A; Hurria A
    J Clin Oncol; 2017 Feb; 35(4):421-431. PubMed ID: 27992272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eligibility criteria in clinical trials in breast cancer: a cohort study.
    Szlezinger K; Pogoda K; Jagiełło-Gruszfeld A; Kłosowska D; Górski A; Borysowski J
    BMC Med; 2023 Jul; 21(1):240. PubMed ID: 37400830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physician-reported reasons for non-enrollment of older adults in cancer clinical trials.
    Lackman M; Vickers MM; Hsu T
    J Geriatr Oncol; 2020 Jan; 11(1):31-36. PubMed ID: 30799176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials.
    Kornblith AB; Kemeny M; Peterson BL; Wheeler J; Crawford J; Bartlett N; Fleming G; Graziano S; Muss H; Cohen HJ;
    Cancer; 2002 Sep; 95(5):989-96. PubMed ID: 12209681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Trial Characteristics and Barriers to Participant Accrual: The MD Anderson Cancer Center Experience over 30 years, a Historical Foundation for Trial Improvement.
    Tang C; Sherman SI; Price M; Weng J; Davis SE; Hong DS; Yao JC; Buzdar A; Wilding G; Lee JJ
    Clin Cancer Res; 2017 Mar; 23(6):1414-1421. PubMed ID: 28275168
    [No Abstract]   [Full Text] [Related]  

  • 12. Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients.
    Lee EQ; Weller M; Sul J; Bagley SJ; Sahebjam S; van den Bent M; Ahluwalia M; Campian JL; Galanis E; Gilbert MR; Holdhoff M; Lesser GJ; Lieberman FS; Mehta MP; Penas-Prado M; Schreck KC; Strowd RE; Vogelbaum MA; Walbert T; Chang SM; Nabors LB; Grossman S; Reardon DA; Wen PY
    Neuro Oncol; 2020 May; 22(5):601-612. PubMed ID: 31974566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Speed of Accrual Into Phase III Oncology Trials: A Comparison Across Geographic Locations.
    Ruther NR; Mathiason MA; Wee SK; Emmel AE; Go RS
    Am J Clin Oncol; 2015 Dec; 38(6):575-82. PubMed ID: 24517955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accrual issues for chemoprevention trials: the example of the 4-HPR study for the prevention of contralateral breast cancer.
    Camerini T; De Palo G; Mariani L; Marubini E; Costa A; Veronesi U
    Tumori; 1999; 85(4):299-303. PubMed ID: 10587038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of prior cancer on trial eligibility and treatment outcomes in nasopharyngeal carcinoma: Implications for clinical trial accrual.
    Wang YQ; Lv JW; Tang LL; Du XJ; Chen L; Li WF; Liu X; Guo Y; Lin AH; Mao YP; Sun Y; Chen YP; Ma J
    Oral Oncol; 2019 Mar; 90():23-29. PubMed ID: 30846172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A sense of urgency: Evaluating the link between clinical trial development time and the accrual performance of cancer therapy evaluation program (NCI-CTEP) sponsored studies.
    Cheng SK; Dietrich MS; Dilts DM
    Clin Cancer Res; 2010 Nov; 16(22):5557-63. PubMed ID: 21062929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study in contrasts: eligibility criteria in a twenty-year sample of NSABP and POG clinical trials. National Surgical Adjuvant Breast and Bowel Program. Pediatric Oncology Group.
    Fuks A; Weijer C; Freedman B; Shapiro S; Skrutkowska M; Riaz A
    J Clin Epidemiol; 1998 Feb; 51(2):69-79. PubMed ID: 9474067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generalisability of Common Oncology Clinical Trial Eligibility Criteria in the Real World.
    Karim S; Xu Y; Kong S; Abdel-Rahman O; Quan ML; Cheung WY
    Clin Oncol (R Coll Radiol); 2019 Sep; 31(9):e160-e166. PubMed ID: 31133363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enrollment of older patients in cancer treatment trials in Canada: why is age a barrier?
    Yee KW; Pater JL; Pho L; Zee B; Siu LL
    J Clin Oncol; 2003 Apr; 21(8):1618-23. PubMed ID: 12697888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges Facing Early Phase Trials Sponsored by the National Cancer Institute: An Analysis of Corrective Action Plans to Improve Accrual.
    Massett HA; Mishkin G; Rubinstein L; Ivy SP; Denicoff A; Godwin E; DiPiazza K; Bolognese J; Zwiebel JA; Abrams JS
    Clin Cancer Res; 2016 Nov; 22(22):5408-5416. PubMed ID: 27401246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.